April 1994
·
8 Reads
Medical Parasitology and Parasitic Diseases
Manufacturing process for anthelmintic embovin in a micronized form have been developed. Embovin in the micronized form exhibited the highest activity.
This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
April 1994
·
8 Reads
Medical Parasitology and Parasitic Diseases
Manufacturing process for anthelmintic embovin in a micronized form have been developed. Embovin in the micronized form exhibited the highest activity.
November 1991
·
6 Reads
·
1 Citation
Medical Parasitology and Parasitic Diseases
The toxicity and anthelminthic activity of the earlier synthetized tricyclic analogues of praziquantel and 4-acylpiperazinones-2 have been studied. Tricyclic compounds have shown the acute toxicity similar to that of praziquantel and neurotoxic effect typical of praziquantel. 4-acylpiperazinones-2 toxicity correlated with their anthelminthic effect. The determination of anthelminthic activity of the above compounds in opisthorchiasis and hymenolepiasis has shown that they are less effective than praziquantel or have no anthelminthic activity. A biological activity-structure relationship has been traced in the compounds under study.
September 1989
·
3 Reads
·
1 Citation
Medical Parasitology and Parasitic Diseases
New formulations have been designed to increase the efficacy and bioavailability of the oral drugs mebendazole and nocodazole and were tested in CBA mice. A considerable increase in efficacy was established for a solid disperse formulation of certain composition with a relatively lower toxicity than in aqueous suspensions of the drugs.
March 1987
·
7 Reads
Medical Parasitology and Parasitic Diseases
March 1987
·
1 Read
Medical Parasitology and Parasitic Diseases
March 1987
·
2 Reads
Medical Parasitology and Parasitic Diseases
March 1987
·
4 Reads
Medical Parasitology and Parasitic Diseases
November 1986
·
2 Reads
Medical Parasitology and Parasitic Diseases
November 1986
·
7 Reads
·
1 Citation
Medical Parasitology and Parasitic Diseases
September 1986
·
3 Reads
Medical Parasitology and Parasitic Diseases
... [29][30] Perimidines exhibit antihelminthic activity. [31][32][33] Neurotropic active systems (stimulants and depressants of the central nervous system have been found out by using perimidines. [34][35][36] Some compounds reveals good antitumor. ...
May 1976
Pharmaceutical Chemistry Journal
... The AIJ was prepared by adding 1.8 g of pancreatin, 1.2 g of edible soda, 24 ml of freshly obtained (thawed, concentrated) ruminant bile, and 20 ml of EDTA trypsin to 100 ml of distilled water (Table 1) 7,8,14 . The resulting mixture was poured into a magnetic stirrer, turned on the magnet rotation mode to 500 rpm, and held for 5 minutes. ...
January 1979
Medical Parasitology and Parasitic Diseases
... For these reasons, many investigators consider the mouse model of hookworm to be non-physiological. Despite that, mice have been used to evaluate numerous chemotherapeutic agents (22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39) and vaccine candidates (21,40 -46) by assessing exacerbation or mitigation of skin and lung infiltrates. Of note, a successful vaccination with γ -irradiated N. americanus in BALB/c mice suggests that a localized Th2 response with an enhanced secretion of IL-4 and a higher IL-4/IFN-γ protein ratio may be important to confer protection against hookworm infections (42). ...
September 1976
Medical Parasitology and Parasitic Diseases
... Sustained-released drug effect studies (Marshall, 1982), evaluation of praziquantel activity against different developmental stages of the parasite (Campos et al., 1984), and efficacy studies on modified derivatives were performed (e.g. Tsizin et al., 1991;Mikhailitsyn et al., 1999). In addition, some studies involving praziquantel focused on the host rather than on the parasite. ...
November 1991
Medical Parasitology and Parasitic Diseases
... [9][10][11] Of particular importance is the differences in the physicochemical properties of the three known polymorphs A, B, and C. 10,12,13 For example, the difference in solubilities of these polymorphs in physiologically relevant media is B > C > A. However, due to the increased toxicity of the highly soluble form B, form C is clinically preferred because its solubility is sufficient to ensure optimal bioavailability. [14][15][16][17] This is important because polymorph A has no anthelminthic activity alone or when present above 30% in polymorphic mixtures. 15,17 Evans et al. 18 in a letter published in the South African Medical Journal asked that regulating authorities require testing to ensure that all batches of mebendazole raw material and tablets contain crystal polymorph C. ...
September 1985
Medical Parasitology and Parasitic Diseases
... Concomitantly, studies on the effects of host influence on migration and circadian rhythm of Hymenolepis worms (Braten and Hopkins, 1969) established that adult Hymenolepis exhibited two concurrent migrations: (a) an age-dependent forward migration and (b) a circadian migration, which is influenced by the host (Tanaka and Maclnnis, 1975). This migration, which could affect, for example, the effectiveness of dehelminthization (Krotov and Rusak, 1973), seemed to be influenced by host interactive and synergistic factors, with final consequences on worm distribution in the small intestine (Dwinell et al., 2001). The influence of hormones on the course of infection was studied in the mouse model (Bailenger et al., 1972;Novak et aL, 1980). ...
September 1973
Medical Parasitology and Parasitic Diseases
... for drug screening studies. The first investigation we could identify dates back to 1971 (Krotov and Gusel'nikova 1971) . The majority of studies employed E. caproni in the mouse, and also E. ilocanum in rats and gerbils (Cross and Basaca-Sevilla 1986) , and E. miyagawai in mice (Krotov and Gusel'nikova 1971) were utilized. ...
November 1971
Medical Parasitology and Parasitic Diseases